Skip to main content

Table 1 Double-Blind Placebo-Controlled Studies of Local Nasal Immunotherapy

From: Local Nasal Specific Immunotherapy for Allergic Rhinitis

Author, Year

Age Range (yrs)

No of Patients (Active/Placebo)

Allergen

Duration

Type of Extract

Johansson, 1979 [13]

Ad

12/11

Grass

14 wk

Aqueous, modified

Nickelsen, 1981 [14]

16-66

38/34

Ragweed

3 mo

Aqueous, modified

Welsh, 1981 [15]

13-58

18/15

Ragweed

20 wk

Aqueous

Schumacher, 1982 [16]

20-53

8/7

Grass

10 wk

Powder, modified

Georgitis, 1983 [17]

16-67

31/13

Grass

10 wk

Aqueous, modified

Georgitis, 1984 [18]

Ad

29/16

Grass

10 wk

Aqueous, modified

Andri, 1992 [19]

14-54

8/8

Parietaria

18 wk

Powder, modified

Andri, 1993 [20]

15-54

11/10

Mite

12 mo

Powder

Passalacqua, 1995 [21]

20-56

9/9

Parietaria

5 mo

Powder

D'Amato, 1995 [22]

13-37

10/10

Parietaria

8 mo

Powder

Andri, 1995 [23]

17-56

14/14

Birch

22 wk

Powder

Fanales-Belasio, 1995 [24]

16-49

10/10

Mite

3 mo

Aqueous

Andri, 1996 [25]

14-52

13/15

Grass

4 mo

Powder

Cirla, 1996 [26]

17-44

11/11

Birch/alder

4 mo

Powder

Bardare, 1996 [27]

5-15

19/20

Grass

3 mo

Powder

Gaglani, 1997 [28]

18-35

13/14

Weed mix

4 mo

Aqueous

Bertoni, 1999 [29]

18-43

10/10

Grass

3 mo

Aqueous

Motta, 2000 [30]

13-55

55/47

Grass/mite

8 mo

Aqueous

Pocobelli, 2001 [31]

16-45

22/21

Grass

4 mo

Powder, modified

Marcucci, 2002 [32]

4-15

16/16

Mite

18 mo

Powder, modified

Passali, 2002 [33]

16-47

18/18

Mite

8 mo

Powder, modified

  1. Ad = advanced age; wk = weeks.